Cargando…
Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis
BACKGROUND: Th17 cells are involved in the pathogenesis of ankylosing spondylitis (AS). However, the mechanism underlying enhanced Th17 cell accumulation in AS remains unknown. The prostaglandin E(2) receptor EP2/EP4 signaling pathway plays a critical role in the development of autoimmune Th17 cells...
Autores principales: | Klasen, Charlotte, Meyer, Anja, Wittekind, Paula S., Waqué, Iris, Nabhani, Schafiq, Kofler, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599260/ https://www.ncbi.nlm.nih.gov/pubmed/31253169 http://dx.doi.org/10.1186/s13075-019-1948-1 |
Ejemplares similares
-
Cannabinoids drive Th17 cell differentiation in patients with rheumatic autoimmune diseases
por: Kotschenreuther, Konstantin, et al.
Publicado: (2020) -
Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020) -
Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
por: Hammitzsch, Ariane, et al.
Publicado: (2018) -
Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling
por: Boniface, Katia, et al.
Publicado: (2009) -
Neutrophil Extracellular Traps and Interleukin 17 in Ankylosing Spondylitis
por: Papagoras, Charalampos, et al.
Publicado: (2021)